Literature DB >> 23321160

Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies.

Z G Zhao1, X G Guo, C X Ba, W Wang, Y Y Yang, J Wang, H Y Cao.   

Abstract

OBJECTIVE: This meta-analysis examined the relationship between excess body weight or body mass index (BMI) and risk of thyroid cancer.
METHODS: PubMed(®), MEDLINE(®), EMBASE™ and Academic Search™ Premier databases were searched to identify cohort studies examining the effect of being overweight or obese on the risk of thyroid cancer.
RESULTS: The inclusion criteria were met by seven cohort studies (total number of thyroid cancer cases, 5154). The pooled relative risk (RR) of thyroid cancer was 1.13 (95% confidence interval [CI] 1.04, 1.22) for overweight. Obesity was also linked with increased thyroid cancer risk in males and females, the strength of the association increasing with increasing BMI. The combined RR of thyroid cancer was 1.18 (95% CI 1.11, 1.25) for excess body weight (overweight and obesity combined). Being overweight was associated with a significant increase in thyroid cancer risk among non-Asians, but not among Asians. Overweight, obesity and excess body weight were all associated with papillary thyroid carcinoma risk.
CONCLUSIONS: The association between overweight/obesity/excess body weight and thyroid cancer risk was confirmed.

Entities:  

Mesh:

Year:  2012        PMID: 23321160     DOI: 10.1177/030006051204000601

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  48 in total

1.  Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma.

Authors:  Zeming Liu; Yusufu Maimaiti; Pan Yu; Yiquan Xiong; Wen Zeng; Xiaoyu Li; Haiping Song; Chong Lu; Yue Xin; Jing Zhou; Ning Zhang; Jie Ming; Chunping Liu; Wei Shi; Lan Shi; Xueqin Li; Xiu Nie; Tao Huang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.

Authors:  A Goday; I Barneto; J M García-Almeida; A Blasco; A Lecube; C Grávalos; P Martínez de Icaya; R de las Peñas; S Monereo; L Vázquez; J E Palacio; P Pérez-Segura
Journal:  Clin Transl Oncol       Date:  2015-06-03       Impact factor: 3.405

3.  Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer.

Authors:  Mustafa Akker; Sibel Güldiken; Tammam Sipahi; Orkide Palabıyık; Ayhan Tosunoğlu; Özlem Çelik; Nermin Tunçbilek; Atakan Sezer; Necdet Süt
Journal:  Mol Biol Rep       Date:  2014-02-07       Impact factor: 2.316

4.  Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study.

Authors:  Peter Dieringer; Evan M Klass; Brenna Caine; Julie Smith-Gagen
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-12       Impact factor: 4.553

Review 5.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER.

Authors:  Louise Davies; Luc G T Morris; Megan Haymart; Amy Y Chen; David Goldenberg; John Morris; Jennifer B Ogilvie; David J Terris; James Netterville; Richard J Wong; Gregory Randolph
Journal:  Endocr Pract       Date:  2015-06       Impact factor: 3.443

6.  Body mass index and incidence of thyroid cancer in Korea: the Korean Cancer Prevention Study-II.

Authors:  Hyun-Young Shin; Yong Ho Jee; Eo Rin Cho
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-23       Impact factor: 4.553

Review 7.  Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment.

Authors:  Seong Lin Teoh; Srijit Das
Journal:  Tumour Biol       Date:  2016-09-14

8.  How Does Managed Care Improve the Quality of Breast Cancer Care Among Medicare-Insured Minority Women?

Authors:  Julie Smith-Gagen; Travis Loux; Chris Drake; Eliseo J Pérez-Stable
Journal:  J Racial Ethn Health Disparities       Date:  2015-10-21

9.  Insulin resistance is another factor that increases the risk of recurrence in patients with thyroid cancer.

Authors:  Fabián Pitoia; Erika Abelleira; Fernanda Bueno; Carolina Urciuoli; Angélica Schmidt; Hugo Niepomniszcze
Journal:  Endocrine       Date:  2014-09-11       Impact factor: 3.633

Review 10.  Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis.

Authors:  Daniela Schmid; Gundula Behrens; Carmen Jochem; Marlen Keimling; Michael Leitzmann
Journal:  Eur J Epidemiol       Date:  2013-11-17       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.